Please login to the form below

Not currently logged in

Former GSK exec joins PureTech Health

Dr Atul Pande becomes chief medical officer

PureTech Health Dr Atul PandeBoston, US-based PureTech Health has appointed Dr Atul Pande as its new chief medical officer, responsible for the firm's pipeline in immune, nervous and gastro-intestinal systems.

Dr Pande was formerly senior vice president and head of neuroscience at GlaxoSmithKline, where he also served as a senior advisor in its R&D division.

Prior to this, he was chief medical officer at Cenerx Biopharma and brings further R&D leadership experience from Pfizer, where he served as vice president for neurosciences.

Dr Pande currently serves on the board of directors for Karuna Pharmaceuticals - part of PureTech Health - as well as Axovant Sciences, Autifony Therapeutics, and Cennerv Pharma's scientific advisory board.

Daphne Zohar, chief executive officer of PureTech Health, said: “We are excited to work more closely with Atul and to have access to his drug development expertise across PureTech Health's pipeline.

“Atul is a seasoned drug development veteran who will help to shepherd our advancing pipeline through mid- and late-stage clinical trials while ensuring that synergies are leveraged across our platforms.”

27th February 2017

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....
The Periodic Table of Healthcare Communications
The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing....